MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Abnormal sense of agency is involved in myoclonus dystonia phenotype through a cerebellar impairment

    C. Tarrano, C. Gallea, M. Vidailhet, E. Roze, Y. Worbe (Paris, France)

    Objective: To investigate the sense of agency in patients with myoclonus-dystonia (DYT-SGCE) compared to healthy volunteers (HV). Background: Sense of agency is an action-related cognitive…
  • 2023 International Congress

    Validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale and the King’s Parkinson’s Disease Pain Questionnaire

    K. Kurihara, S. Zfujioka, T. Mishima, Y. Tsuboi (Fukuoka, Japan)

    Objective: The purpose of this study is a validation of the Japanese version of the King's Parkinson's Disease Pain Scale (KPPS) and the King's Parkinson's…
  • 2023 International Congress

    Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia

    S. Gorcenco, E. Kafantari, J. Wallenius, C. Karremo, E. Alinder, S. Dobloug, M. Landqvist Waldö, E. Englund, H. Ehrencrona, K. Wictorin, K. Karrman, A. Puschmann (Lund, Sweden)

    Objective: In this study, we aimed to examine clinically and genetically a patient series with ataxia from southern Sweden with known or unknown genetic causes.…
  • 2023 International Congress

    Functional circuit abnormalities in Levodopa-induced dyskinesia in Parkinson’s disease: A systematic review

    B. Thomsen, M. Vinding, D. Meder, L. Marner, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)

    Objective: Levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD) are involuntary movements caused by long-term treatment with dopaminergic replacement therapy (levodopa). During the cause of PD,…
  • 2023 International Congress

    Sleep quality in GBA, LRRK2 and idiopathic Parkinson disease

    A. Yoo, R. Ortega, D. Raymond, B. Plitnick, M. Markgraf, J. Liang, M. Rawal, A. Wise, M. Pullman, K. Leaver, V. Katsnelson, J. Miravite, V. Shanker, M. Swan, M. Figueiro, S. Bressman, R. Saunders-Pullman (New York, USA)

    Objective: To describe sleep characteristics and quality in GBA, LRRK2 and non-genetic idiopathic Parkinson disease. Background: Sleep disturbances are one of the most common non-motor…
  • 2023 International Congress

    Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease

    L. Morris, S. Harrison, T. Melzer, J. Dalrymple-Alford, T. Anderson, M. Macaskill, C. Le Heron (Christchurch, New Zealand)

    Objective: To investigate whether changes in connectivity between neural regions that are associated with goal-directed behaviour predict future development of apathy in people with Parkinson’s…
  • 2023 International Congress

    CBS presenting rapidly progressive anterior operculum syndrome with suggested background pathology of 4-repeat tauopathy by tau PET: A case report

    K. Nakamura, Y. Kuroha, M. Hatakeyama, A. Kimura, Y. Nakamura, Y. Murakami, M. Watanabe, H. Igarashi, T. Takahashi, H. Shimada (Niigata city, Japan)

    Objective: Report of a case with suspected TDP-43 proteinopathy as the pathological background in the early stage of the disease, and a final diagnosis of…
  • 2023 International Congress

    A strategic training framework for building research capacity in the Global Parkinson’s Genetics Program (GP2)

    MT. Periñan, S. Dey, C. Bale, M. Kuhl, H. Leonard, P. Lewis, S. Stott, MB. Makarious, A. Martinez-Carrasco, AJ. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Seville, Spain)

    Objective: To promote and facilitate learning internationally with resources and expertise to serve the training needs of the Global Parkinson’s Genetics Program (GP2;www.gp2.org) and its…
  • 2023 International Congress

    Deep Brain Stimulation for Orthostatic Tremor: An observational study’

    W. Babeliowsky, M. Bot, W. Potters, P. Vanden Munckhof, E. Blok, R. de Bie, P. Schuurman, AF. van Rootselaar (Amsterdam, Netherlands)

    Objective: To evaluate the efficacy of stimulation near the DRT on OT, based on standing time and QoL, and relate the proximity of stimulation to…
  • 2023 International Congress

    Levodopa Carbidopa Intestinal Gel for Parkinson’s Disease over 11 years: A Single Center “Real-World” Experience

    C. Vekhande, M. Hamed, G. Tremain, J. Mah, A. Shetty, A. Lazarescu, O. Suchowersky (Edmonton, Canada)

    Objective: To review long-term real-world experience and clinical outcomes in PD patients with LCIG therapy over 11 years in a multidisciplinary University clinic setting. Background:…
  • « Previous Page
  • 1
  • …
  • 217
  • 218
  • 219
  • 220
  • 221
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley